Knoll Capital Management LLC Invests $5.21 Million in MeiraGTx Holdings plc (NASDAQ:MGTX)

Knoll Capital Management LLC acquired a new stake in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,250,000 shares of the company’s stock, valued at approximately $5,212,000. MeiraGTx makes up about 2.6% of Knoll Capital Management LLC’s investment portfolio, making the stock its 11th largest position. Knoll Capital Management LLC owned about 1.93% of MeiraGTx at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MGTX. Privium Fund Management B.V. grew its position in MeiraGTx by 70.0% in the second quarter. Privium Fund Management B.V. now owns 203,960 shares of the company’s stock worth $804,000 after acquiring an additional 83,975 shares in the last quarter. Dimensional Fund Advisors LP grew its position in MeiraGTx by 14.6% in the second quarter. Dimensional Fund Advisors LP now owns 462,950 shares of the company’s stock worth $1,949,000 after acquiring an additional 58,854 shares in the last quarter. Royce & Associates LP grew its position in MeiraGTx by 5.3% in the third quarter. Royce & Associates LP now owns 795,392 shares of the company’s stock worth $3,317,000 after acquiring an additional 40,000 shares in the last quarter. Hobbs Group Advisors LLC acquired a new stake in shares of MeiraGTx in the second quarter worth $164,000. Finally, SkyView Investment Advisors LLC acquired a new stake in shares of MeiraGTx in the second quarter worth $126,000. 67.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Royal Bank of Canada boosted their price objective on shares of MeiraGTx from $9.00 to $11.00 and gave the stock an “outperform” rating in a research note on Thursday, November 14th. Chardan Capital restated a “buy” rating and issued a $36.00 price objective on shares of MeiraGTx in a research note on Monday, November 18th.

MeiraGTx Stock Up 2.5 %

MGTX stock opened at $6.55 on Friday. MeiraGTx Holdings plc has a 1-year low of $3.85 and a 1-year high of $7.60. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86. The business’s 50 day moving average is $5.44 and its 200-day moving average is $4.85.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.